February 28, 2026
ABT · NYQ · USD
vs. prev. close $116.26
Last updated Feb 27, 2026 21:02
Intraday Chart — 5-min intervals
Abbott Laboratories (ABT) is trading marginally up, at $116.35 — up 0.08% from yesterday's close of $116.26. Recent news includes "Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval" and "Grail’s Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech.". The broader market is under pressure (S&P 500: -0.4%, Nasdaq: -0.9%, Dow Jones: -1.1%, Shanghai: +0.4%, Hang Seng: +0.9%, Nikkei 225: +0.2%, FTSE 100: +0.6%, Nifty 50: -1.2%, DAX: -0.0%, OMX Stockholm: +0.5%). Past performance does not guarantee future results.
Auto-generated · less than a minute ago
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval
Grail’s Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech.
Assessing Abbott Laboratories (ABT) Valuation After Mixed Share Performance And Conflicting Fair Value Signals
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
Is Abbott Laboratories Stock Underperforming the Nasdaq?
S&P 500
-0.43%
Nasdaq
-0.92%
Dow Jones
-1.05%
Shanghai
+0.39%
Hang Seng
+0.95%
Nikkei 225
+0.16%
FTSE 100
+0.59%
Nifty 50
-1.25%
DAX
-0.02%
OMX Stockholm
+0.55%
Search another stock